JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

Search

Geron Corp

Fechado

SetorSaúde

1.27 3.25

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.23

Máximo

1.27

Indicadores-chave

By Trading Economics

Rendimento

3.5M

-16M

Vendas

9.4M

49M

Margem de lucro

-33.394

Funcionários

229

EBITDA

9.2M

-7.6M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+182.26% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

40M

810M

Abertura anterior

-1.98

Fecho anterior

1.27

Sentimento de Notícias

By Acuity

50%

50%

309 / 373 Ranking em Healthcare

Geron Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de out. de 2025, 23:32 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL Delays Flu-Vaccine Spinoff, Cuts Guidance As U.S. Vaccination Rates Decline

27 de out. de 2025, 23:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Australia's AUB Opens Books to EQT After Receiving $3.44 Billion Takeover Offer

27 de out. de 2025, 21:42 UTC

Ganhos

Waste Management 3Q Revenue Climbs, Sees Fiscal Year Revenue at Low End of Prior View

27 de out. de 2025, 23:43 UTC

Conversa de Mercado

Nikkei May Rise on Easing U.S.-China Trade Tensions -- Market Talk

27 de out. de 2025, 23:42 UTC

Conversa de Mercado

Gold Rises on Likely Technical Recovery -- Market Talk

27 de out. de 2025, 23:37 UTC

Conversa de Mercado

Investors May Cheer CSL's Decision to Delay Seqirus Spinoff -- Market Talk

27 de out. de 2025, 23:00 UTC

Ganhos

The Good Vibes Are Back on Wall Street -- WSJ

27 de out. de 2025, 22:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Australia's AUB Opens Books to EQT After Receiving $3.44B Takeover Offer

27 de out. de 2025, 22:06 UTC

Conversa de Mercado
Ganhos

Nucor Expects Weaker Steel Market in 4Q -- Market Talk

27 de out. de 2025, 22:05 UTC

Ganhos

China Southern Airlines: Continued Improvements in Business Environment Supported Results >1055.HK

27 de out. de 2025, 22:04 UTC

Ganhos

Cadence Reports Solid Earnings. The Stock Is Falling. -- Barrons.com

27 de out. de 2025, 22:04 UTC

Ganhos

China Southern Airlines 3Q Net CNY3.84B, Up 20.3% on Year >1055.HK

27 de out. de 2025, 22:03 UTC

Ganhos

China Southern Airlines 3Q Rev CNY51.37B, Up 3.0% on Year >1055.HK

27 de out. de 2025, 21:27 UTC

Ganhos

Waste Management 3Q Rev Climbs, Sees FY Rev at Low End of Prior View

27 de out. de 2025, 21:19 UTC

Ganhos

Cadence Reports Solid Earnings. The Stock Is Falling. -- Barrons.com

27 de out. de 2025, 20:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

27 de out. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

27 de out. de 2025, 20:37 UTC

Ganhos

Waste Management: Decrease From Prior Rev Expectations Is Primarily Related to Further Decline in Recycled Commodity Pricing, Modestly Lower Rev Expectations From Healthcare Solutions >WM

27 de out. de 2025, 20:37 UTC

Ganhos

Waste Management: 2025 Free Cash Flow Guidance Remains Between $2.8B and $2.9B >WM

27 de out. de 2025, 20:37 UTC

Ganhos

Waste Management: 2025 Total Co Rev Is Now Expected Approximately $25.275B >WM

27 de out. de 2025, 20:37 UTC

Ganhos

Waste Management: Affirming 2025 Adjusted Operating EBITDA Guidance Between $7.475B and $7.625B >WM

27 de out. de 2025, 20:31 UTC

Ganhos

Nucor Sees 4Q Earnings Lower Than 3Q

27 de out. de 2025, 20:30 UTC

Ganhos

Nucor 3Q Steel Mills Total Shipments 6.43M Tons >NUE

27 de out. de 2025, 20:30 UTC

Ganhos

Nucor 3Q EPS $2.63 >NUE

27 de out. de 2025, 20:30 UTC

Ganhos

Nucor 3Q Net $607M >NUE

27 de out. de 2025, 20:30 UTC

Ganhos

Nucor 3Q Sales $8.52B >NUE

27 de out. de 2025, 20:30 UTC

Ganhos

Nucor 3Q Total Tons Shipped to Outside Customers Down 1% >NUE

27 de out. de 2025, 20:30 UTC

Ganhos

Waste Management 3Q Adj EPS $1.98 >WM

27 de out. de 2025, 20:30 UTC

Ganhos

Waste Management 3Q Rev $6.44B >WM

27 de out. de 2025, 20:30 UTC

Ganhos

Waste Management 3Q Net $603M >WM

Comparação entre Pares

Variação de preço

Geron Corp Previsão

Preço-alvo

By TipRanks

182.26% parte superior

Previsão para 12 meses

Média 3.5 USD  182.26%

Máximo 5 USD

Mínimo 1.5 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Geron Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

6 ratings

4

Comprar

2

Manter

0

Vender

Sentimento

By Acuity

309 / 373 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
help-icon Live chat